Sarah Finocchario-Kessler

Sarah Finocchario-Kessler

Auto-generated profile, based on publicly available information

Sarah Finocchario-Kessler

Department of Family Medicine, University of Kansas Medical Center, Kansas City, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2016 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
SFSarah Finocchario-Kessler
Sarah Finocchario-Kessler
CWCatherine Wexler
Catherine Wexler
MMMay Maloba
May Maloba
NMNatabhona Mabachi
Natabhona Mabachi
FNFlorence Ndikum-Moffor
Florence Ndikum-Moffor
EBElizabeth Bukusi
Elizabeth Bukusi
Women living in Africa experience the highest burden of cervical cancer. Research and investment to improve vaccination, screening, and treatment efforts are critically needed. We systematically reviewed and characterized recent research within a broader public health framework to organize and assess the range of cervical cancer research in Africa. We searched online databases and the Internet for published articles and cervical cancer reports in African countries. Inclusion criteria included publication between 2004 and 2014, cervical cancer-related content pertinent to one of the four public health categories (primary, secondary, tertiary prevention or quality of life), and conducted in or specifically relevant to countries or regions within the African continent. The study design, geographic region/country, focus of research, and key findings were documented for each eligible article and summarized to illustrate the weight and research coverage in each area. Publications with more than one focus (e.g. secondary and tertiary prevention) were categorized by the primary emphasis of the paper. Research specific to HIV-infected women or focused on feasibility issues was delineated within each of the four public health categories. A total of 380 research articles/reports were included. The majority (54.6 %) of cervical cancer research in Africa focused on secondary prevention (i.e., screening). The number of publication focusing on primary prevention (23.4 %), particularly HPV vaccination, increased significantly in the past decade. Research regarding the treatment of precancerous lesions and invasive cervical cancer is emerging (17.6 %), but infrastructure and feasibility challenges in many countries have impeded efforts to provide and evaluate treatment. Studies assessing aspects of quality of life among women living with cervical cancer are severely limited (4.1 %). Across all categories, 11.3 % of publications focused on cervical cancer among HIV-infected women, while 17.1 % focused on aspects of feasibility for cervical cancer control efforts. Cervical cancer research in African countries has increased steadily over the past decade, but more is needed. Tertiary prevention (i.e. treatment of disease with effective medicine) and quality of life of cervical cancer survivors are two severely under-researched areas. Similarly, there are several countries in Africa with little to no research ever conducted on cervical cancer.

1 July 2014 in AIDS
Verified
Journal Article
Closed access
SFSarah Finocchario-Kessler
Sarah Finocchario-Kessler
BGBrad J. Gautney
Brad J. Gautney
SKSamoel Khamadi
Samoel Khamadi
VOVincent Okoth
Vincent Okoth
KGKathy Goggin
Kathy Goggin
GPGeoffrey A. Preidis
Geoffrey A. Preidis
Objective: The objective of this study is to evaluate the impact of the HIV Infant Tracking System (HITSystem) for quality improvement of early infant diagnosis (EID) of HIV services. Design and Setting: This observational pilot study compared 12 months of historical preintervention EID outcomes at one urban and one peri-urban government hospital in Kenya to 12 months of intervention data to assess retention and time throughout the EID cascade of care. Participants: Mother–infant pairs enrolled in EID at participating hospitals before (n = 320) and during (n = 523) the HITSystem pilot were eligible to participate. Intervention: The HITSystem utilizes Internet-based coordination of the multistep PCR cycle, automated alerts to trigger prompt action from providers and laboratory technicians, and text messaging to notify mothers when results are ready or additional action is needed. Main outcome measures: The main outcome measures were retention throughout EID services, meeting time-sensitive targets and improving results turn-around time, and increasing early antiretroviral therapy (ART) initiation among HIV-infected infants. Results: The HITSystem was associated with an increase in the proportion of HIV-exposed infants retained in EID care at 9 months postnatal (45.1–93.0% urban; 43.2–94.1% peri-urban), a decrease in turn-around times between sample collection, PCR results and notification of mothers in both settings, and a significant increase in the proportion of HIV-infected infants started on antiretroviral therapy at each hospital(14 vs. 100% urban; 64 vs. 100% peri-urban). Conclusion: The HITSystem maximizes the use of easily accessible technology to improve the quality and efficiency of EID services in resource-limited settings.

8 August 2014 in Health Care for Women International
Verified
Journal Article
Closed access
SFSarah Finocchario-Kessler
Sarah Finocchario-Kessler
RWRhoda Wanyenze
Rhoda Wanyenze
DMDeborah Mindry
Deborah Mindry
JBJolly Beyeza-Kashesya
Jolly Beyeza-Kashesya
KGKathy Goggin
Kathy Goggin
GWGlenn Wagner
Glenn Wagner
In this qualitative study, researchers assessed knowledge, acceptability, and feasibility of safer conception methods (SCM; timed unprotected intercourse [TUI], manual self-insemination, and sperm washing) among various health care providers (n = 33) and 48 HIV clients with recent or current childbearing intentions in Uganda. While several clients and providers had heard of SCM (especially TUI), few fully understood how to use the methods. All provider types expressed a desire to incorporate SCM into their practice; however, this will require training and counseling protocols, sensitization to overcome cultural norms that pose obstacles to these methods, and partner engagement (particularly by men) in safer conception counseling.

1 December 2018 in The Lancet HIV
Verified
Journal Article
Closed access
SFSarah Finocchario-Kessler
Sarah Finocchario-Kessler
BGBrad Gautney
Brad Gautney
ACAnLin Cheng
AnLin Cheng
CWCatherine Wexler
Catherine Wexler
MMMay Maloba
May Maloba
KGKathy Goggin
Kathy Goggin

1 December 2015 in Healthcare
Verified
Journal Article
Closed access
SFS. Finocchario-Kessler
S. Finocchario-Kessler
IOI. Odera
I. Odera
VOV. Okoth
V. Okoth
CBC. Bawcom
C. Bawcom
BGB. Gautney
B. Gautney
KGK. Goggin
K. Goggin

1 March 2016 in AIDS Patient Care and STDs
Verified
Journal Article
Closed access
SFSarah Finocchario-Kessler
Sarah Finocchario-Kessler
SCSofie Champassak
Sofie Champassak
MHMary Jo Hoyt
Mary Jo Hoyt
WSWilliam Short
William Short
RCRana Chakraborty
Rana Chakraborty
JAJean Anderson
Jean Anderson
Pre-exposure prophylaxis (PrEP) can reduce the risk of HIV transmission among serodifferent couples trying to conceive, yet provider knowledge, attitudes, and experience utilizing PrEP for this purpose are largely unexamined. Trained interviewers conducted phone interviews with healthcare providers treating patients with HIV in seven cities (Atlanta, Baltimore, Houston, Kansas City, Newark, Philadelphia, and San Francisco, N = 85 total). Quantitative and qualitative data were analyzed to describe experience, concerns, and perceived barriers to prescribing PrEP for safer conception. Providers (67.1% female, 43 mean years of age, 70.4% white, 10 mean years treating HIV+ patients, 56% in academic vs. community facilities, 62.2% MD) discussed both benefits and concerns of PrEP for safer conception among serodifferent couples. Only 18.8% of providers reported experience prescribing PrEP, 74.2% were willing to prescribe it under ideal circumstances, and 7.0% were not comfortable prescribing PrEP. Benefits included added protection and a greater sense of control for the HIV-negative partner. Concerns were categorized as clinical, system-level, cost, or behavioral. Significant differences in provider characteristics existed across sites, but experience with PrEP for safer conception did not, p = 0.14. Despite limited experience, most providers were open to recommending PrEP for safer conception as long as patients understood the range of concerns and could make informed decisions. Strategies to identify and link serodifferent couples to PrEP services and clinical guidance specific to PrEP for safer conception are needed.